Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

ShockWave Medical Inc (SWAV) USD0.001

Sell:$125.58 Buy:$126.04 Change: $4.24 (3.48%)
Market closed |  Prices as at close on 24 February 2021 | Switch to live prices |
Change: $4.24 (3.48%)
Market closed |  Prices as at close on 24 February 2021 | Switch to live prices |
Change: $4.24 (3.48%)
Market closed |  Prices as at close on 24 February 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ShockWave Medical, Inc. is a medical device company. The Company is focused on developing and commercializing products and establish care for medical device treatment of atherosclerotic cardiovascular disease. Its IVL System, which leverages IVL Technology, is a minimally invasive and improve patient outcomes. IVL System includes a generator, connector cable and a variety of IVL catheters designed to treat PAD and CAD. IVL Technology to crack calcium through short bursts of sonic pressure waves, which are generated within the IVL catheter, travel through the vessel and crack calcium with an effective pressure of up to 50 atmospheres (atm) (a unit of pressure) without harming the soft tissue.

Contact details

5403 Betsy Ross Dr
United States
+1 (510) 2794262

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$4.17 billion
Shares in issue:
34.26 million
Health Care Equipment
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • C. Raymond Larkin
    Independent Chairman of the board
  • Douglas Godshall
    President, Chief Executive Officer, Director
  • Daniel Puckett
    Chief Financial Officer
  • Isaac Zacharias
    Chief commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.